Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Kidney360|April 4, 2022
A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKDKristen L Nowak, Rahul Kakkar, Matt Devalaraja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJohn R Johnson, Peter Bross, Martin Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2017
Exposure-Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia PatientsCarl LaCerte, Vijay Ivaturi, Joga Gobburu, et al.
Journal of Chromatographic Science|July 9, 2021
Quantitation of Cabozantinib in Human Plasma by LC-MS/MSReyna Jones, Julianne Holleran, Robert A Parise, et al.
Clinical Pharmacology in Drug Development|May 17, 2024
A Model-Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular RiskChenna Keshava Reddy Sannala, Carol MacLean, Finn Larsen, et al.
Expert Review of Clinical Pharmacology|November 25, 2011
Knowledge management for efficient quantitative analyses during regulatory reviewsKevin Krudys, Fang Li, Jeffry Florian, et al.
Acta Diabetologica|February 18, 2018
Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus<sup>®</sup>) and Lantus<sup>®</sup> in healthy subjects: a double-blind, randomized clamp studyAshima Bhatia, Shraddha Tawade, Mushtaque Mastim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylateMichael Brave, Vicki Goodman, Edvardas Kaminskas, et al.
Pageof 2